CATALYST PHARMACEUTICALS, INC. Business Operations Contracts & Agreements
5 Contracts & Agreements
- Collaboration Agreements (1 contract)
- Settlement Agreements (2)
- Supply Agreements (1)
- Termination Agreements (1)
- License and Collaboration Agreement, executed and delivered as of June 19, 2023, by and between Santhera, its wholly-owned subsidiary, Santhera Pharmaceuticals (Schweiz) AG, and... (Filed With SEC on June 23, 2023)
- Form of Supply Agreement between Eisai and the Company (certain identified information has been excluded from the exhibit because it both (i) is not material and (ii) would be... (Filed With SEC on December 22, 2022)
- Settlement Agreement, dated July 11, 2022, by and between the Company and SERB SA, on the one hand, and Jacobus Pharmaceutical Company Inc., PantherRx Specialty LLC, and Panther... (Filed With SEC on July 12, 2022)
- Settlement Agreement, effective as of July 26, 2018, among the Company, BioMarin Pharmaceutical Inc. and Aceras BioMedical LLC, in its capacity as stockholder representative for... (Filed With SEC on August 7, 2018)
- TERMINATION AGREEMENT (Filed With SEC on November 13, 2013)
